Stock listing
Chemocentryx Inc.
Selected listing: CCXI · BOATS · USD · US
Chemocentryx Inc. (BOATS:CCXI), Finance. Latest release Jul 23, 2026: Agility Robotics Strengthens Executive Leadership Team with Appointment of Michael Beer…
- Ticker
- BOATS:CCXI
- Asset type
- Stock
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- BOATS
- Currency
- USD
About Chemocentryx Inc.
The company focuses on developing innovative therapies for autoimmune diseases and cancer. Chemocentryx is dedicated to advancing its pipeline of drug candidates to address unmet medical needs in these therapeutic areas.
Latest news from Chemocentryx Inc.
Agility Robotics Strengthens Executive Leadership Team with Appointment of Michael Beer as Chief Financial Officer
July 23, 2026
Agility Robotics and Churchill Capital Corp XI Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
July 14, 2026
Agility Robotics to Go Public Through $2.5 Billion Merger with Churchill Capital Corp XI
June 24, 2026
Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026
February 5, 2026
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
October 16, 2022